查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2047976

豬隻人工授精市場：全球產業規模、佔有率、趨勢、機會和預測（按產品、分銷管道、最終用戶和地區分類），競爭格局（2021-2031 年）

Swine Artificial Insemination Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Distribution Channel, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球豬人工授精市場預計將從 2025 年的 22.1 億美元大幅成長至 2031 年的 32.3 億美元，複合年成長率達 6.53%。

這項輔助生殖技術，即透過人工方式將公豬精液注入母豬生殖器官進行受精，其發展源於對遺傳最佳化的迫切需求，以確保肉質優良並最大限度地降低自然交配帶來的疾病傳播風險。此外，減少公豬飼養數量和提高母豬生產力的經濟效益也推動了這項技術的廣泛應用。預計到2025年6月，中國種豬存欄量將達到4,043萬頭，凸顯了依賴高效育種方案的養殖規模之大。市場的主要促進因素是全球豬肉消費量的成長以及由此帶來的對優質動物蛋白需求的上升。這迫使生產者利用人工授精技術，在商業豬群中快速傳播優良遺傳性狀，確保肉質一致性，並最大限度地提高產量以滿足國際出口需求。美國強勁的豬肉出口就是一個典型的例子。大規模工業化養豬場的擴張進一步鞏固了人工授精的優勢。這些農場優先考慮生物安全，實施封閉式畜群管理以最大限度減少疾病傳入，並利用精準遺傳學最佳化飼料轉換率和提高畜群抗病能力。主要基因供應商的強勁財務表現也反映了這一趨勢。

市場概覽
預測期 2027-2031
市場規模：2025年 22.1億美元
市場規模：2031年 32.3億美元
複合年成長率：2026-2031年 6.53%
成長最快的細分市場 私人的
最大的市場 亞太地區

市場促進因素

全球對豬肉和優質動物性蛋白質的需求不斷成長，是推動豬肉成長要素。由於消費者傾向於選擇更精瘦、品質更穩定、更安全的肉品，生產商正採用人工授精技術，以便快速將優良的遺傳性狀推廣到商業豬群中。這確保了肉質的一致性，並最大限度地提高了每頭母豬的蛋白質產量，這對滿足國際出口要求至關重要。例如，預計到2025年2月，美國豬肉出口量將飆升至303萬噸以上，價值超過86.3億美元。大規模工業化商業養豬場的擴張進一步強化了人工授精的作用，因為這些養豬場優先考慮生物安全和運營效率，利用人工授精技術來維持封閉式豬群，並最大限度地減少可能通過活體種豬傳播的跨境疾病的引入。此外，這些營業單位正在利用精準遺傳學來最佳化飼料轉換率和畜群復原力，這種向高科技育種的轉變體現在 Genus plc 預計其生豬部門 (PIC) 2025 年的調整後營業利潤為 1.119 億英鎊，並且預計在先進的育種方案的推動下，其在巴西全球豬肉生產中的市場佔有率將擴大到 15%。

市場挑戰

全球人工授精市場擴張的一大障礙是豬群容易受到非洲豬瘟等跨境疾病侵襲。在疫情嚴重爆發期間，必須對受感染或接觸過病源的豬群進行大規模撲殺，這直接減少了可用於人工授精的種母豬數量。這導致精液和服務需求立即下降。此外，為控制這些疾病而實施的嚴格檢疫措施和流動限制會擾亂該行業至關重要的物流網路，因為人工授精高度依賴透過穩定的低溫運輸及時運送新鮮公豬精液。區域封鎖往往癱瘓這些運輸網路，例如2025年7月越南爆發的非洲豬瘟疫情，疫情導致超過970例非洲豬瘟病例（超過10萬頭豬受到影響）。因此，此類生物威脅的不可預測性阻礙了長期投資，並限制了人工授精技術的穩定推廣應用。此外，實施治療和管理低溫運輸物流需要熟練的技術人員，這對於基礎設施有限的發展中地區來說是一個重大障礙。

市場趨勢

受高衛生標準遺傳資源生產規模經濟需求的驅動，市場正經歷著向大規模集中式公豬育種運作的結構性轉變。遺傳資源供應商正在整合資產以加強生物安全和研究，以工業規模的設施取代小規模分散的精液採集中心。這種集中化有利於能夠持續進行大量資本投資的營運商，因為它加強了對疾病傳播途徑的控制並簡化了分銷網路。 Topigs Norsvin 預計到 2025 年銷售額將超過 3 億歐元，這得益於其一體化營運的策略擴張，也印證了這一點。同時，基因組選擇在商業人工授精計畫中的應用，透過量化具有重要經濟意義的性狀，正在徹底改變單份精液的提案。先進的育種項目現在正利用龐大的資料集，以比傳統表現型選擇更快的速度預測和傳播飼料轉換率和存活率等性狀。這確保了用於人工授精的每一份精子都能透過提高豬群生產力為養豬戶帶來可衡量的經濟效益，DanBred 的基因組學計劃到 2025 年每年可使每頭肥育豬的育種進展達到 2.48 歐元。

目錄

第1章：引言

第2章 分析方法

第3章執行摘要

第4章：客戶心聲

第5章：全球豬人工授精市場展望

  • 市場規模及預測
    • 以金額為準
  • 市佔率及預測
    • 依產品分類（儀器、精液、試劑、試劑盒、服務）
    • 分銷通路（私營、公營）
    • 依最終用戶（醫院、診所等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美生豬人工授精市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲生豬人工授精市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區生豬人工授精市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲豬人工授精市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美豬人工授精市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 企業合併（M&A）
  • 產品發布
  • 近期趨勢

第13章：全球豬人工授精市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客購買力
  • 替代品的威脅

第15章 競爭格局

  • Genus plc
  • IMV Technologies SADIR
  • Shipley Swine Genetics
  • Agtech Inc
  • Neogen Corp
  • Genpro Inc
  • Minitub GmbH
  • Swine Genetics International
  • Hypor BV
  • Semen Cardona

第16章 策略建議

第17章 關於TSCI與免責聲明

簡介目錄
Product Code: 17581

The Global Swine Artificial Insemination Market is projected to expand significantly from USD 2.21 Billion in 2025 to USD 3.23 Billion by 2031, achieving a 6.53% CAGR. This assisted reproductive technology, involving the manual delivery of collected boar semen into a sow's reproductive tract for fertilization, is driven by a critical need for genetic optimization to ensure superior meat quality and minimize disease transmission risks associated with natural mating. Additionally, the economic benefits derived from reducing the number of resident boars and maximizing sow output support its widespread adoption, with China's breeding sow inventory reaching 40.43 million head in June 2025, underscoring the scale of operations reliant on efficient breeding protocols. The market's primary catalyst is the rising global consumption of pork and the corresponding demand for high-quality animal protein, compelling producers to use artificial insemination for rapidly disseminating superior genetic traits across commercial herds, ensuring uniformity in meat quality and maximizing output to meet international export requirements, exemplified by robust U.S. pork exports. The expansion of large-scale industrialized swine operations further cements AI's dominance, as these farms prioritize biosecurity, maintain closed herds to minimize disease entry, and leverage precision genetics to optimize feed conversion ratios and herd resilience, a trend reflected in the strong financial performance of major genetic providers.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.21 Billion
Market Size 2031USD 3.23 Billion
CAGR 2026-20316.53%
Fastest Growing SegmentPrivate
Largest MarketAsia Pacific

Market Driver

The increasing global demand for pork and high-quality animal protein is a primary catalyst, as consumer preference for lean, consistent, and safe meat products drives producers to adopt artificial insemination to rapidly disseminate superior genetic traits across commercial herds. This ensures uniformity in meat quality and maximizes protein output per sow, vital for meeting international export requirements; for instance, U.S. pork exports surged to 3.03 million metric tons valued over $8.63 billion in February 2025. The expansion of large-scale, industrialized commercial swine operations further reinforces AI's role, as these farms prioritize biosecurity and operational efficiency by utilizing AI to maintain closed herds and minimize the entry of transboundary diseases that can be transmitted through live boars. Moreover, these entities leverage precision genetics to optimize feed conversion ratios and herd resilience, a shift towards high-tech breeding reflected in the £111.9 million adjusted operating profit of Genus plc's porcine division (PIC) in 2025 and Brazil's projected market share expansion to 15% of global pork volumes, driven by advanced breeding protocols.

Market Challenge

A formidable barrier to the global artificial insemination market's expansion is the susceptibility of swine populations to transboundary diseases like African Swine Fever. Severe outbreaks necessitate mass depopulation of infected and exposed herds, directly reducing the inventory of breeding sows available for insemination and causing an immediate contraction in demand for semen doses and services. Furthermore, strict quarantine protocols and movement restrictions enforced to contain these diseases sever the logistical lines essential for the industry, as AI relies heavily on the time-sensitive delivery of fresh boar semen through a stable cold chain. Regional lockdowns often halt these transport networks, as seen with Vietnam's over 970 ASF outbreaks affecting more than 100,000 pigs in July 2025. Consequently, the unpredictability of such biological threats hampers long-term investment and limits the consistent adoption of insemination technologies, alongside the requirement for skilled technicians to perform the procedure and manage cold chain logistics, which acts as a significant barrier in developing regions with limited infrastructure.

Market Trends

The market is experiencing a structural shift towards the consolidation into large-scale centralized boar stud operations, driven by the need for economies of scale in high-health genetic production. Genetic providers are merging assets to pool resources for enhanced biosecurity and research, replacing smaller, fragmented collection centers with industrial-grade facilities. This centralization enables tighter control over disease vectors and more efficient distribution networks, favoring entities capable of sustaining high capital investments, as evidenced by Topigs Norsvin's turnover exceeding €300 million in 2025, driven by strategic expansion of integrated operations. Simultaneously, the application of genomic selection in commercial AI programs is revolutionizing the value proposition of semen doses by quantifying economically important traits. Advanced breeding programs now utilize vast datasets to predict and disseminate traits such as feed efficiency and survival rates more rapidly than traditional phenotypic selection, ensuring that each insemination dose delivers measurable financial returns to pork producers through enhanced herd performance, with DanBred's genomic program achieving an annual breeding progress valued at EUR 2.48 per finisher pig in 2025.

Key Market Players

  • Genus plc
  • IMV Technologies SADIR
  • Shipley Swine Genetics
  • Agtech Inc
  • Neogen Corp
  • Genpro Inc
  • Minitub GmbH
  • Swine Genetics International
  • Hypor BV
  • Semen Cardona

Report Scope

In this report, the Global Swine Artificial Insemination Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Swine Artificial Insemination Market, By Product

  • Equipment
  • Semen
  • Reagent
  • Kit
  • Service

Swine Artificial Insemination Market, By Distribution Channel

  • Private
  • Public

Swine Artificial Insemination Market, By End User

  • Hospitals
  • Clinics
  • Others

Swine Artificial Insemination Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Swine Artificial Insemination Market.

Available Customizations:

Global Swine Artificial Insemination Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Swine Artificial Insemination Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Equipment, Semen, Reagent, Kit, Service)
    • 5.2.2. By Distribution Channel (Private, Public)
    • 5.2.3. By End User (Hospitals, Clinics, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Swine Artificial Insemination Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Distribution Channel
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Swine Artificial Insemination Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Distribution Channel
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Swine Artificial Insemination Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Distribution Channel
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Swine Artificial Insemination Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Distribution Channel
        • 6.3.3.2.3. By End User

7. Europe Swine Artificial Insemination Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Distribution Channel
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Swine Artificial Insemination Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Distribution Channel
        • 7.3.1.2.3. By End User
    • 7.3.2. France Swine Artificial Insemination Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Distribution Channel
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Swine Artificial Insemination Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Distribution Channel
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Swine Artificial Insemination Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Distribution Channel
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Swine Artificial Insemination Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Distribution Channel
        • 7.3.5.2.3. By End User

8. Asia Pacific Swine Artificial Insemination Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Distribution Channel
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Swine Artificial Insemination Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Distribution Channel
        • 8.3.1.2.3. By End User
    • 8.3.2. India Swine Artificial Insemination Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Distribution Channel
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Swine Artificial Insemination Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Distribution Channel
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Swine Artificial Insemination Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Distribution Channel
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Swine Artificial Insemination Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Distribution Channel
        • 8.3.5.2.3. By End User

9. Middle East & Africa Swine Artificial Insemination Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Distribution Channel
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Swine Artificial Insemination Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Distribution Channel
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Swine Artificial Insemination Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Distribution Channel
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Swine Artificial Insemination Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Distribution Channel
        • 9.3.3.2.3. By End User

10. South America Swine Artificial Insemination Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Distribution Channel
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Swine Artificial Insemination Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Distribution Channel
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Swine Artificial Insemination Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Distribution Channel
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Swine Artificial Insemination Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Distribution Channel
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Swine Artificial Insemination Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Genus plc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. IMV Technologies SADIR
  • 15.3. Shipley Swine Genetics
  • 15.4. Agtech Inc
  • 15.5. Neogen Corp
  • 15.6. Genpro Inc
  • 15.7. Minitub GmbH
  • 15.8. Swine Genetics International
  • 15.9. Hypor BV
  • 15.10. Semen Cardona

16. Strategic Recommendations

17. About Us & Disclaimer